Polar Asset Management Partners Inc. Vaxcyte, Inc. Transaction History
Polar Asset Management Partners Inc.
- $2.77 Billion
- Q1 2025
A detailed history of Polar Asset Management Partners Inc. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 10,004 shares of PCVX stock, worth $372,148. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,004Holding current value
$372,148% of portfolio
0.01%Shares
9 transactions
Others Institutions Holding PCVX
# of Institutions
345Shares Held
136MCall Options Held
348KPut Options Held
250K-
Ra Capital Management, L.P. Boston, MA12.2MShares$453 Million9.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$448 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X011.8MShares$438 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$370 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA6.42MShares$239 Million0.05% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.21B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...